Stay updated on KZR-616 in SLE: Clinical Trial
Sign up to get notified when there's something new on the KZR-616 in SLE: Clinical Trial page.

Latest updates to the KZR-616 in SLE: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information about the Phase 1b/2 study of zetomipzomib and the introduction of new references to KZR-616 and Lupus Nephritis.SummaryDifference25%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check81 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check96 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to KZR-616 in SLE: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KZR-616 in SLE: Clinical Trial page.